Patel Sunil
Insider CIK 1503062 · OMED See Remarks · OABI Director · LGND Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OABI OmniAb, Inc. | A Award deriv | 2023-06-23 | 2023-06-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2023-06-23 | 2023-06-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2023-01-30 | 2023-02-01 | 37,840 | — | $0 | 37,840 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2023-01-30 | 2023-02-01 | 8,753 | — | $0 | 224,265 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2022-11-09 | 2022-11-10 | 43,000 | $2.77 | $119.1K | 215,512 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | D To issuer deriv | 2022-11-01 | 2022-11-03 | 4,340 | — | $0 | 0 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 10,565 | — | $0 | 10,565 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 17,427 | — | $0 | 17,427 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 10,590 | — | $0 | 10,590 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 9,970 | — | $0 | 9,970 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 11,789 | — | $0 | 11,789 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 14,178 | — | $0 | 14,178 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 13,994 | — | $0 | 13,994 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 37,840 | — | $0 | 37,840 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 10,513 | — | $0 | 10,513 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | D To issuer | 2022-11-01 | 2022-11-03 | 1,004 | — | $0 | 28,820 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2022-11-01 | 2022-11-03 | 172,512 | — | $0 | 172,512 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-06-10 | 2022-06-13 | 4,340 | — | $0 | 4,340 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-06-10 | 2022-06-13 | 1,004 | — | $0 | 29,824 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2021-06-04 | 2021-06-07 | 3,269 | — | $0 | 3,269 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-06-04 | 2021-06-07 | 630 | — | $0 | 28,820 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2020-11-02 | 2020-11-04 | 1,000 | $82.52 | $82.5K | 28,190 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2020-06-10 | 2020-06-12 | 2,468 | — | $0 | 2,468 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2020-06-10 | 2020-06-12 | 831 | — | $0 | 27,190 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-08-02 | 2019-08-05 | 1,000 | $95.98 | $96.0K | 26,359 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2019-06-06 | 2019-06-07 | 4,071 | — | $0 | 4,071 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-06-06 | 2019-06-07 | 835 | — | $0 | 25,359 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-08-16 | 2018-08-17 | 5,000 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-08-16 | 2018-08-17 | 7,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-08-16 | 2018-08-17 | 7,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-08-16 | 2018-08-17 | 7,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-08-16 | 2018-08-17 | 5,000 | $9.60 | $48.0K | 44,806 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-08-16 | 2018-08-17 | 7,335 | $10.12 | $74.2K | 52,141 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-08-16 | 2018-08-17 | 7,335 | $12.53 | $91.9K | 59,476 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-08-16 | 2018-08-17 | 7,335 | $32.30 | $236.9K | 66,811 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-08-16 | 2018-08-17 | 42,287 | $240.05 | $10.15M | 24,524 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-06-19 | 2018-07-03 | 2,474 | — | $0 | 2,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-06-19 | 2018-06-21 | 2,474 | — | $0 | 2,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-06-19 | 2018-06-21 | 493 | — | $0 | 39,806 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2018-01-04 | 2018-01-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-10-10 | 2017-10-12 | 46 | $4.27 | $196 | 69,538 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-10-10 | 2017-10-12 | 1,202 | $4.24 | $5.1K | 68,336 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-10-07 | 2017-10-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2017-10-07 | 2017-10-10 | 25,000 | — | $0 | 69,584 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2017-05-25 | 2017-05-26 | 2,456 | $113.50 | $278.8K | 2,456 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-05-25 | 2017-05-26 | 666 | — | $0 | 39,313 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-04-23 | 2017-04-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2017-04-23 | 2017-04-25 | 20,000 | — | $0 | 44,584 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-04-04 | 2017-04-05 | 5,711 | $9.06 | $51.7K | 24,584 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-04-04 | 2017-04-05 | 43 | $8.87 | $381 | 30,295 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-01-03 | 2017-01-05 | 65,000 | — | $0 | 65,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2016-10-09 | 2016-10-11 | 12,500 | — | $0 | 30,338 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2016-05-23 | 2016-05-25 | 2,329 | $119.30 | $277.8K | 2,329 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2016-05-23 | 2016-05-25 | 622 | — | $0 | 38,647 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-07 | 2016-01-08 | 1 | $21.33 | $21 | 17,838 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-06 | 2016-01-08 | 69 | $21.65 | $1.5K | 17,839 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-06 | 2016-01-08 | 2,092 | $22.30 | $46.7K | 17,908 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2015-12-27 | 2015-12-29 | 70,000 | — | $0 | 70,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2015-04-24 | 2015-04-27 | 2,754 | $89.75 | $247.2K | 2,754 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2015-04-24 | 2015-04-27 | 925 | — | $0 | 38,025 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-03-20 | 2015-03-23 | 14,665 | — | $0 | 101,595 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-03-20 | 2015-03-23 | 14,665 | $3.42 | $50.2K | 34,665 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-03-20 | 2015-03-23 | 14,665 | $27.86 | $408.6K | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-03-19 | 2015-03-23 | 3,335 | — | $0 | 116,260 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-03-19 | 2015-03-20 | 4,591 | $74.42 | $341.7K | 37,100 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-03-19 | 2015-03-23 | 3,335 | $3.42 | $11.4K | 23,335 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-03-19 | 2015-03-23 | 3,335 | $27.34 | $91.2K | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2014-12-18 | 2014-12-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2014-06-04 | 2014-06-05 | 3,312 | $67.53 | $223.7K | 3,312 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-06-04 | 2014-06-05 | 1,151 | — | $0 | 41,691 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2014-03-25 | 2014-03-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2013-07-17 | 2013-07-19 | 14,000 | — | $0 | 14,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2013-06-11 | 2013-06-12 | 7,335 | $32.30 | $236.9K | 7,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2013-06-11 | 2013-06-12 | 1,393 | — | $0 | 40,540 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2013-06-11 | 2013-06-12 | 2,925 | — | $0 | 39,147 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2012-05-31 | 2012-05-31 | 7,335 | — | $0 | 7,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2012-05-31 | 2012-05-31 | 3,592 | — | $0 | 36,222 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2012-05-31 | 2012-05-31 | 2,925 | — | $0 | 32,630 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2012-05-23 | 2012-05-24 | 100 | $11.35 | $1.1K | 28,305 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2012-05-23 | 2012-05-24 | 100 | $11.35 | $1.1K | 28,405 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2012-05-23 | 2012-05-24 | 20 | $11.35 | $227 | 28,425 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2012-05-23 | 2012-05-24 | 31 | $11.37 | $352 | 28,456 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2012-05-23 | 2012-05-24 | 1,249 | $11.39 | $14.2K | 29,705 | SEC↗ |